JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2006; 47:1959-1966, doi:10.1016/j.jacc.2005.12.057 (Published online 24 April 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antoniades, C.
Right arrow Articles by Stefanadis, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antoniades, C.
Right arrow Articles by Stefanadis, C.

Genetic Polymorphisms of Platelet Glycoprotein Ia and the Risk for Premature Myocardial Infarction

Effects on the Release of sCD40L During the Acute Phase of Premature Myocardial Infarction

Charalambos Antoniades, MD, Dimitris Tousoulis, MD, PhD, FACC*, Carmen Vasiliadou, BSc, MSc, Elli Stefanadi, MD, Kyriakoula Marinou, MD and Christodoulos Stefanadis, MD, FACC, FESC

Athens University Medical School, 1st Cardiology Department, Hippokration Hospital, Athens, Greece.


Figure 1
View larger version (14K):

[in a new window]
  		Figure 1 Serum levels of soluble CD40 ligand (sCD40L) were significantly higher in carriers of the 807T allele both during the acute phase of myocardial infarction (MI) and one year after the event in the same subjects, compared with 807CC homozygotes. Although sCD40L level was increased in all genotypes during the acute phase of MI compared with the values one year after the event, the increase in 807T carriers was greater than the increase in 807CC homozygotes (p < 0.05). Levels of sCD40L were similar between the genotypes in the control group. Solid bars = carriers of the 807T allele (807TT + 807CT); open bars = 807CC homozygotes. *p < 0.01 vs. CC; {dagger}p < 0.01 vs. acute phase (after Bonferroni correction); {ddagger}p < 0.01 vs. controls (after Bonferroni correction).

 

Figure 2
View larger version (21K):

[in a new window]
  		Figure 2 (A) In the control group, carriers of the 807T allele (807TT + 807CT) had significantly higher levels of soluble CD40 ligand (sCD40L) compared with 807CC homozygotes in the presence of high levels of von Willebrand factor (vWF ≥ median), while there was no difference in sCD40L between genotypes among healthy individuals with vWF < median (vWF median in controls: 72.84%). (B) Carriers of the 807T allele had significantly higher levels of sCD40L compared with 807CC one year after myocardial infarction (MI) independently from plasma vWF levels (vWF median for follow-up group: 87.1%). (C) Similarly, the presence of the 807T allele was associated with higher levels of sCD40L during the acute phase of MI, independently from vWF levels (median for vWF during the acute phase of MI: 92.12%). Solid bars = Carriers of the 807T allele (807TT + 807CT); open bars = 807CC homozygotes; *p < 0.05 and **p < 0.01 vs. carriers of T allele.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.